Page last updated: 2024-08-23

staurosporine and damnacanthal

staurosporine has been researched along with damnacanthal in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M	1
Faltynek, CR; Kelley, M; Lehr, R; Mauvais, P; Maycock, A; Michne, W; Miller, D; Murphy, D; Schroeder, J; Wang, S	1
Arase, Y; Chen, Z; Hiwasa, T; Ito, H; Kita, K; Suzuki, N; Umezawa, K	1
Elbaum, D; Lydon, NB; Toledo, LM	1
Hawkins, J; Marcy, A	1

Reviews

1 review(s) available for staurosporine and damnacanthal

Article	Year
The structure-based design of ATP-site directed protein kinase inhibitors. Current medicinal chemistry, 1999, Volume: 6, Issue:9 Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Anthraquinones; Binding Sites; Catalytic Domain; Cyclin-Dependent Kinases; Drug Design; Enzyme Inhibitors; Humans; Kinetin; Piperazines; Protein-Tyrosine Kinases; Purines; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Receptors, Growth Factor; Roscovitine; Staurosporine; Structure-Activity Relationship	1999

Article

Year

The structure-based design of ATP-site directed protein kinase inhibitors.

Current medicinal chemistry, 1999, Volume: 6, Issue:9

Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Anthraquinones; Binding Sites; Catalytic Domain; Cyclin-Dependent Kinases; Drug Design; Enzyme Inhibitors; Humans; Kinetin; Piperazines; Protein-Tyrosine Kinases; Purines; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Receptors, Growth Factor; Roscovitine; Staurosporine; Structure-Activity Relationship

1999

Other Studies

4 other study(ies) available for staurosporine and damnacanthal

Article	Year
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51 Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases	2007
Damnacanthal is a highly potent, selective inhibitor of p56lck tyrosine kinase activity. Biochemistry, 1995, Sep-26, Volume: 34, Issue:38 Topics: Alkaloids; Anthraquinones; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kinetics; Lipids; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Peptides; Phosphorylation; Polylysine; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Ribonuclease, Pancreatic; src-Family Kinases; Staurosporine	1995
Stimulation of ultraviolet-induced apoptosis of human fibroblast UVr-1 cells by tyrosine kinase inhibitors. FEBS letters, 1999, Feb-12, Volume: 444, Issue:2-3 Topics: Anthraquinones; Apoptosis; Benzoquinones; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; Cell Line; DNA Fragmentation; Enzyme Inhibitors; Genistein; Humans; Indole Alkaloids; Indoles; Lactams, Macrocyclic; Maleimides; Microscopy, Phase-Contrast; Nuclear Proteins; Phosphorylation; Protein-Tyrosine Kinases; Quinones; Rifabutin; Staurosporine; Ultraviolet Rays	1999
Characterization of Itk tyrosine kinase: contribution of noncatalytic domains to enzymatic activity. Protein expression and purification, 2001, Volume: 22, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphate; Amino Acid Sequence; Animals; Anthraquinones; Catalysis; Catalytic Domain; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Genetic Vectors; Humans; Kinetics; Mice; Molecular Sequence Data; Phosphoprotein Phosphatases; Protein-Tyrosine Kinases; Proteins; Recombinant Proteins; RNA-Binding Proteins; Sequence Deletion; src-Family Kinases; Staurosporine; Substrate Specificity	2001